Li-Fraumeni syndrome in a Turkish family

Pediatric Hematology and Oncology

Volumn 27, Issue 4, 2010, Pages 297-305

  Karakas, Zeynep ^a   Tugcu, Deniz ^a   Unuvar, Aysegul ^a   Atay, Didem ^a   Akcay, Arzu ^a   Gedik, Hakan ^a   Kayserili, Hulya ^a   Dogan, Oner ^a   Anak, Sema ^a   Devecioglu, Omer ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Acute lymphoblastic leukemia; Adrenocortical cancer; Li Fraumeni syndrome

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYTARABINE; FLUDARABINE; IDARUBICIN; MACROGOL; MITOTANE; MOLECULAR MARKER; PROTEIN P53;

ABDOMINAL PAIN; ABDOMINAL TENDERNESS; ACUTE LYMPHOBLASTIC LEUKEMIA; ADRENAL CORTEX CARCINOMA; ANAPHYLAXIS; ANAPLASTIC CARCINOMA; ANEMIA; ANXIETY; ARTHRALGIA; ARTICLE; BRAIN EDEMA; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SCREENING; CANCER SURGERY; CASE REPORT; CHILD; CLINICAL FEATURE; CONSANGUINITY; CONTRAST ENHANCEMENT; CRANIOTOMY; DISEASE ASSOCIATION; DNA DETERMINATION; EARLY DIAGNOSIS; ECHOGRAPHY; EPENDYMOMA; EXOPHTHALMOS; EYE MOVEMENT DISORDER; FAMILIAL CANCER; FAMILY HISTORY; FATIGUE; FEMALE; FEVER; GENE MUTATION; GENETIC COUNSELING; GENETIC DISORDER; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MALE; MYALGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PATHOGENESIS; PATIENT REFERRAL; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL WELL BEING; RELIABILITY; SPINAL CORD; STOMACH PAIN; THROMBOCYTOPENIA; THROMBOCYTOSIS; TREATMENT RESPONSE; TURKEY (REPUBLIC);

ADRENOCORTICAL CARCINOMA; AMINO ACID SUBSTITUTION; BRAIN NEOPLASMS; CHILD, PRESCHOOL; FAMILY; FEMALE; HUMANS; LI-FRAUMENI SYNDROME; MALE; MUTATION, MISSENSE; NEOPLASMS, SECOND PRIMARY; PEDIGREE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TUMOR SUPPRESSOR PROTEIN P53; TURKEY;

EID: 77951861391     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880011003663374     Document Type: Article

References (24)

1. Li FP, Fraumeni JF Jr. Soft-tissue sarcomas, breast cancer, and other neoplasm. A familial syndrome? Ann Intern Med. 1969; 71: 747-752.
2. Li FP, Fraumeni JF Jr, Mulvihill JJ, et al. A cancer family syndrome in twenty-four kindred. Cancer Res. 1988; 48: 5358-5362.
3. Li FP, Garber JE, Friend SH, et al. Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. J Natl Cancer Inst. 1992; 84: 1156-1160.
4. Li YJ, Sanson M, Hoang-Xuan K, et al. Incidence of germ-line p53 mutations in patients with gliomas. Int J Cancer. 1995; 64: 383-387.
5. Olivier M, Goldgar DE, Sodha N, et al. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res. 2003; 63: 6643-6650.
6. Birch JM, Hartley AL, Tricker KJ, et al. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res. 1994; 54: 1298-304.
7. Eeles RA. Germ line mutations in the TP53 gene [review]. Cancer Surv. 1995; 25: 101-124.
8. Malkin D, Li FP, Strong LC, Fraumeni JF, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasm. Science. 1990; 250: 1233-1238.
9. Kleihues P, Schauble B, Zur HA, et al. Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol. 1997; 150: 1-13.
10. Wong SS, Lozano G, Gaff CL, et al. Novel p53 germ line mutation in a patient with Li-Fraumeni syndrome. Intern Med J. 2003; 33: 621-623.
11. Bendig I, Mohr N, Kramer F, Weber BH. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin. Cancer Genet Cytogenet. 2004; 154: 22-26.
12. Sandrini R, Ribeiro RC, DeLacerda L. Childhood adrenocortical tumors. J Clin Endocrinol Metab. 1997; 82: 2027-2031.
13. Michalkiewicz E, Sandrini R, Figueiredo B, et al. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol. 2004; 22: 838-845.
14. Abramson DH, Beaverson K, Sangani P, et al. Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival. Pediatrics. 2003; 112: 1248-1255.
15. Lalloo F, Varley J, Ellis D, et al, and the early onset breast cancer study Group. Family history is predictive of pathogenic mutations in BRCA1, BRCA2 and TP53 with high penetrance in a population based study of very early onset breast cancer. Lancet. 2003; 361: 1101-1102.
16. Moule RN, Jhavar SG, Eeles RA. Genotype phenotype correlation in Li-Fraumeni syndrome kindreds and its implications for management. Fam Cancer. 2006; 5: 129-133.
17. Varley JM, McGown G, Thorncroft M, et al. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res. 1997; 57: 3245-3252.
18. Birch JM, Alston RD, McNally RJQ, et al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene. 2001; 20: 4621-4628.
19. Varley JM, Evans DGR, Birch JM. Li-Fraumeni syndrome-a molecular and clinical review. Br J Cancer. 1997; 76: 1-14.
20. Evans DGR, Morrison P. The ethical and insurance issues in testing for cancer predisposition genes. In: Eeles R, Ponder B, Easton D, Eng C, Horwich A, eds. Genetic Predisposition to Cancer. 2nd ed. London: Chapman and Hall; 2004:414-423.
21. Evans DGR, Maher ER, Macleod R, et al. Uptake of genetic testing for cancer predisposition. J Med Genet. 1997; 34: 746-748.
22. Evans DG, Lunt P, Clancy T, Eeles R. Childhood predictive genetic testing for Li-Fraumeni syndrome. Fam Cancer. 2009; 9: 65-69.
23. Chompret A, Brugieres L, Ronsin M, et al. P53 germ line mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer. 2000; 82: 1932-1937.
24. Varley JM. Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mutat. 2003; 21: 313-320.